Drugs / octreotide pamoate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01469338 | Jul 2012 → Oct 2014 | diarrheal disease, hormone-resistant prostate carcinoma | University of Southern California | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | octreotide pamoate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01469338 ↗ |
| Route | Intramuscular | “octreotide pamoate given as intramuscular (IM) injection” NCT01469338 ↗ |